Myositis as a neuromuscular complication of immune checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Myositis as a neuromuscular complication of immune checkpoint inhibitors

Published:2020-01-29 Issue:2 Volume:120 Page:355-364
ISSN:0300-9009
Container-title:Acta Neurologica Belgica
language:en
Short-container-title:Acta Neurol Belg

Author:

Vermeulen Lynn^ORCID,Depuydt Christophe E.,Weckx Petra,Bechter Oliver,Van Damme Philip,Thal Dietmar R.,Claeys Kristl G.

Funder

Fonds Wetenschappelijk Onderzoek

Universitaire Ziekenhuizen Leuven, KU Leuven

CSL Behring

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13760-020-01282-w.pdf

Reference44 articles.

1. Kreamer KM (2014) Immune checkpoint blockade: a new paradigm in treating advanced cancer. J Adv Pract Oncol 5(6):418–431

2. Chen L, Han X (2015) Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest 125(9):3384–3391. https://doi.org/10.1172/JCI80011

3. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbe C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711–723. https://doi.org/10.1056/NEJMoa1003466

4. Lipson EJ, Forde PM, Hammers HJ, Emens LA, Taube JM, Topalian SL (2015) Antagonists of PD-1 and PD-L1 in cancer treatment. Semin Oncol 42(4):587–600. https://doi.org/10.1053/j.seminoncol.2015.05.013

5. Sadreddini S, Baradaran B, Aghebati-Maleki A, Sadreddini S, Shanehbandi D, Fotouhi A, Aghebati-Maleki L (2018) Immune checkpoint blockade opens a new way to cancer immunotherapy. J Cell Physiol. https://doi.org/10.1002/jcp.27816

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor-induced Myositis;Rheumatic Disease Clinics of North America;2024-05

2. Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis;Current Cardiology Reports;2023-07-12

3. Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review;International Journal of Molecular Sciences;2023-06-30

4. Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors;Frontiers in Immunology;2023-03-23

5. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis;Annals of the Rheumatic Diseases;2023-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3